Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Australian Pharmaceutical Industries Announces Conditional Proposal from Wesfarmers

12 Jul 2021  |  09:11:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Conditional proposal for API from Wesfarmers

Australian Pharmaceutical Industries announced that it has received an unsolicited, non-binding, conditional indicative proposal (the Indicative Proposal) from Wesfarmers to acquire 100% of the shares in the Company by way of a scheme of arrangement. The indicative price of $1.38 cash per share represents a premium of 18.7% to its VWAP for the 3 months prior to 9 July 2021 and a premium of 20.5% to its closing share price on 9 July 2021.

Please click here for full details

See more ASX300 News Announcements